BI-22 CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

BACKGROUND: Factors that correlate the extent of clinical benefit with anti-VEGF therapy are poorly understood. Two phase 3 trials in newly diagnosed GBM (AVAglio and RTOG-0825) reported that BEV + RT/TMZ prolonged progression-free survival but not OS, versus placebo + RT/TMZ. Specific GBM patient s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Phillips, Heidi, Sandmann, Thomas, Li, Congfen, Cloughesy, Timothy, Chinot, Olivier L., Wick, Wolfgang, Nishikawa, Ryo, Mason, Warren, Henriksson, Roger, Saran, Frank, Lai, Albert, Moore, Nicola, Hegde, Priti, Abrey, Lauren, Bourgon, Richard, Garcia, Josep, Bais, Carlos
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2014
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217890/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou239.22
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk